User login
Vascular surgeons spend much of their clinical time taking care of patients with lower extremity occlusive disease, so the “New Devices and Techniques for Treating Lower Extremity Occlusive Disease; Prosthetic Grafts and Heparin Bonding” session on Thursday afternoon will be particularly useful for the practicing surgeon, according to Dr. Russell Samson who will co-moderate the session along with Dr. Ali F. AbuRahma of West Virginia University.
Two recent advances with respect to such alternative graft options, which will be addressed during the session, are heparin-bonded ePTFE and spiral laminar flow grafts.
“Whether these two modalities improve patency rates compared to standard ePTFE grafts remains controversial,” Dr. Samson said.
Heparin-bonded ePTFE will be the topic of a debate presented by Dr. Richard Neville of George Washington University Hospital, and Dr. Jonathan Beard of Sheffield Vascular Institute, in the United Kingdom. These two experts will conduct a debate. Dr. Neville will discuss long-term patency data suggesting that heparin bonding is valuable in PTFE Fempop Bypass Grafts, and Dr. Beard will argue that it does not improve results.
Additionally, Dr. Yann Gouëffic of the University of Nantes, France, will address the cost-efficiency of heparin bonding.
“In an age where surgeons are becoming more cost conscious, new graft configurations, which are often more costly, need to offer significant improvement in long-term outcomes,” Dr. Samson said.
As for spiral laminar flow grafts, Dr. Hosam F. El Sayed of Ohio State University will provide insight into a specific format of PTFE that creates a spiral laminar flow that more accurately represents flow within the arterial system, Dr. Samson noted.
Therefore, Dr. Enrico Ascher of Lutheran Medical Center, who is highly regarded for his experience in performing distal tibial bypass, will provide insight into how to deal with “pipe-like” calcified arteries that some surgeons may consider inoperable, Dr. Samson added.
Further, since many surgeons may prefer an endovascular procedure as a first-line alternative to bypass, this session will also include a talk by Dr. Hiroyoshi Yokoi of Fukuoka Sanno Hospital in Japan on advanced guidewire techniques to open these distal vessels, and another by noted inventor, Dr. Timothy A.M. Chuter of the University of California, San Francisco, who will discuss advantages and early clinical experience with a novel balloon that does not straighten when it inflates.
Another talk during the session, which will be given by Dr. Joseph L. Mills of Baylor College of Medicine, will focus on the impact of foot infections on leg bypass outcomes in CLI patients and what can be done to offset that impact.
“Dr. Mills will remind us that no matter what treatment we choose, the final result can be spoiled by an infection, so managing foot infections in patients requiring surgical bypass becomes a preeminent consideration,” Dr. Samson said.
“The practicing vascular surgeon deals with challenging infrainguinal atherosclerotic conditions on a daily basis. Therefore, information gained from attending this program should enhance their ability to offer long-lasting therapies,” he added.
Session 59
“New Devices and Techniques for Treating Lower Extremity Occlusive Disease; Prosthetic Grafts and Heparin Bonding”
Thursday, 1:00 p.m. – 1:54 p.m.
Grand Ballroom West, 3rd Floor
Vascular surgeons spend much of their clinical time taking care of patients with lower extremity occlusive disease, so the “New Devices and Techniques for Treating Lower Extremity Occlusive Disease; Prosthetic Grafts and Heparin Bonding” session on Thursday afternoon will be particularly useful for the practicing surgeon, according to Dr. Russell Samson who will co-moderate the session along with Dr. Ali F. AbuRahma of West Virginia University.
Two recent advances with respect to such alternative graft options, which will be addressed during the session, are heparin-bonded ePTFE and spiral laminar flow grafts.
“Whether these two modalities improve patency rates compared to standard ePTFE grafts remains controversial,” Dr. Samson said.
Heparin-bonded ePTFE will be the topic of a debate presented by Dr. Richard Neville of George Washington University Hospital, and Dr. Jonathan Beard of Sheffield Vascular Institute, in the United Kingdom. These two experts will conduct a debate. Dr. Neville will discuss long-term patency data suggesting that heparin bonding is valuable in PTFE Fempop Bypass Grafts, and Dr. Beard will argue that it does not improve results.
Additionally, Dr. Yann Gouëffic of the University of Nantes, France, will address the cost-efficiency of heparin bonding.
“In an age where surgeons are becoming more cost conscious, new graft configurations, which are often more costly, need to offer significant improvement in long-term outcomes,” Dr. Samson said.
As for spiral laminar flow grafts, Dr. Hosam F. El Sayed of Ohio State University will provide insight into a specific format of PTFE that creates a spiral laminar flow that more accurately represents flow within the arterial system, Dr. Samson noted.
Therefore, Dr. Enrico Ascher of Lutheran Medical Center, who is highly regarded for his experience in performing distal tibial bypass, will provide insight into how to deal with “pipe-like” calcified arteries that some surgeons may consider inoperable, Dr. Samson added.
Further, since many surgeons may prefer an endovascular procedure as a first-line alternative to bypass, this session will also include a talk by Dr. Hiroyoshi Yokoi of Fukuoka Sanno Hospital in Japan on advanced guidewire techniques to open these distal vessels, and another by noted inventor, Dr. Timothy A.M. Chuter of the University of California, San Francisco, who will discuss advantages and early clinical experience with a novel balloon that does not straighten when it inflates.
Another talk during the session, which will be given by Dr. Joseph L. Mills of Baylor College of Medicine, will focus on the impact of foot infections on leg bypass outcomes in CLI patients and what can be done to offset that impact.
“Dr. Mills will remind us that no matter what treatment we choose, the final result can be spoiled by an infection, so managing foot infections in patients requiring surgical bypass becomes a preeminent consideration,” Dr. Samson said.
“The practicing vascular surgeon deals with challenging infrainguinal atherosclerotic conditions on a daily basis. Therefore, information gained from attending this program should enhance their ability to offer long-lasting therapies,” he added.
Session 59
“New Devices and Techniques for Treating Lower Extremity Occlusive Disease; Prosthetic Grafts and Heparin Bonding”
Thursday, 1:00 p.m. – 1:54 p.m.
Grand Ballroom West, 3rd Floor
Vascular surgeons spend much of their clinical time taking care of patients with lower extremity occlusive disease, so the “New Devices and Techniques for Treating Lower Extremity Occlusive Disease; Prosthetic Grafts and Heparin Bonding” session on Thursday afternoon will be particularly useful for the practicing surgeon, according to Dr. Russell Samson who will co-moderate the session along with Dr. Ali F. AbuRahma of West Virginia University.
Two recent advances with respect to such alternative graft options, which will be addressed during the session, are heparin-bonded ePTFE and spiral laminar flow grafts.
“Whether these two modalities improve patency rates compared to standard ePTFE grafts remains controversial,” Dr. Samson said.
Heparin-bonded ePTFE will be the topic of a debate presented by Dr. Richard Neville of George Washington University Hospital, and Dr. Jonathan Beard of Sheffield Vascular Institute, in the United Kingdom. These two experts will conduct a debate. Dr. Neville will discuss long-term patency data suggesting that heparin bonding is valuable in PTFE Fempop Bypass Grafts, and Dr. Beard will argue that it does not improve results.
Additionally, Dr. Yann Gouëffic of the University of Nantes, France, will address the cost-efficiency of heparin bonding.
“In an age where surgeons are becoming more cost conscious, new graft configurations, which are often more costly, need to offer significant improvement in long-term outcomes,” Dr. Samson said.
As for spiral laminar flow grafts, Dr. Hosam F. El Sayed of Ohio State University will provide insight into a specific format of PTFE that creates a spiral laminar flow that more accurately represents flow within the arterial system, Dr. Samson noted.
Therefore, Dr. Enrico Ascher of Lutheran Medical Center, who is highly regarded for his experience in performing distal tibial bypass, will provide insight into how to deal with “pipe-like” calcified arteries that some surgeons may consider inoperable, Dr. Samson added.
Further, since many surgeons may prefer an endovascular procedure as a first-line alternative to bypass, this session will also include a talk by Dr. Hiroyoshi Yokoi of Fukuoka Sanno Hospital in Japan on advanced guidewire techniques to open these distal vessels, and another by noted inventor, Dr. Timothy A.M. Chuter of the University of California, San Francisco, who will discuss advantages and early clinical experience with a novel balloon that does not straighten when it inflates.
Another talk during the session, which will be given by Dr. Joseph L. Mills of Baylor College of Medicine, will focus on the impact of foot infections on leg bypass outcomes in CLI patients and what can be done to offset that impact.
“Dr. Mills will remind us that no matter what treatment we choose, the final result can be spoiled by an infection, so managing foot infections in patients requiring surgical bypass becomes a preeminent consideration,” Dr. Samson said.
“The practicing vascular surgeon deals with challenging infrainguinal atherosclerotic conditions on a daily basis. Therefore, information gained from attending this program should enhance their ability to offer long-lasting therapies,” he added.
Session 59
“New Devices and Techniques for Treating Lower Extremity Occlusive Disease; Prosthetic Grafts and Heparin Bonding”
Thursday, 1:00 p.m. – 1:54 p.m.
Grand Ballroom West, 3rd Floor